Current Cancer Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular drug targets involved in cancer, e.g. disease specific proteins, receptors, enzymes, genes.
Each issue of the journal contains a series of timely in-depth reviews written by leaders in the field covering a range of current topics on drug targets involved in cancer.
As the discovery, identification, characterization and validation of novel human drug targets for anti-cancer drug discovery continues to grow; this journal has become essential reading for all pharmaceutical scientists involved in drug discovery and development.

Publisher: Bentham Science Publishers

Related content
Volume 10, Number 2, March 2010

< previous issue | all issues | next issue >

Articles

Favourites:Add to Favourites

ROCK Inhibitors as Emerging Therapeutic Candidates for Sarcomas
pp. 127-134(8)
Authors: Micuda, S.; Rosel, D.; Ryska, A.; Brabek, J.

Favourites:Add to Favourites

Understanding FOXO, New Views on Old Transcription Factors
pp. 135-146(12)
Authors: Zanella, F.; Link, W.; Carnero, A.

Favourites:Add to Favourites

Pharmacological Modulation of Genome and Proteome Alterations in Mice Treated with the Endocrine Disruptor Bisphenol A
pp. 147-154(8)
Authors: Izzotti, A.; Longobardi, M.; Cartiglia, C.; D'Agostini, F.; Kanitz, S.; De Flora, S.

Favourites:Add to Favourites

Free Content Dexamethasone Synergizes with Lenalidomide to Inhibit Multiple Myeloma Tumor Growth, But Reduces Lenalidomide-Induced Immunomodulation of T and NK Cell Function
pp. 155-167(13)
Authors: K. Gandhi, A.; Kang, J.; Capone, L.; Parton, A.; Wu, L.; H. Zhang, L.; Mendy, D.; Lopez-Girona, A.; Tran, T.; Sapinoso, L.; Fang, W.; Xu, S.; Hampton, G.; B. Bartlett, J.; Schafer, P.

Favourites:Add to Favourites

Ras-Induced Resistance to Lapatinib is Overcome by MEK Inhibition
pp. 168-175(8)
Authors: Zoppoli, G.; Moran, E.; Soncini, D.; Cea, M.; Garuti, A.; Rocco, I.; Cirmena, G.; Grillo, V.; Bagnasco, L.; Icardi, G.; Ansaldi, F.; Parodi, S.; Patrone, F.; Ballestrero, A.; Nencioni, A.

Favourites:Add to Favourites

Gefitinib Targets EGFR Dimerization and ERK1/2 Phosphorylation to Inhibit Pleural Mesothelioma Cell Proliferation
pp. 176-191(16)
Authors: E. Favoni, R.; Pattarozzi, A.; Casto, M.; Barbieri, F.; Gatti, M.; Paleari, L.; Bajetto, A.; Porcile, C.; Gaudino, G.; Mutti, L.; Corte, G.; Florio, T.

Favourites:Add to Favourites

Structure-Activity Studies on Arylamides and Arysulfonamides Ras Inhibitors
pp. 192-199(8)
Authors: Colombo, S.; Palmioli, A.; Airoldi, C.; Tisi, R.; Fantinato, S.; Olivieri, S.; De Gioia, L.; Martegani, E.; Peri, F.

Favourites:Add to Favourites

Anti-GD2 Antibody Therapy for GD2-Expressing Tumors
pp. 200-209(10)
Authors: Navid, F.; M. Santana, V.; C. Barfield, R.

Favourites:Add to Favourites

Inhibitors of HDACs - Effective Drugs Against Cancer?
pp. 210-228(19)
Authors: Muller, S.; H. Kramer, O.

Favourites:Add to Favourites

Antitumor Effect of Butanoylated Heparin with Low Anticoagulant Activity on Lung Cancer Growth in Mice and Rats
pp. 229-241(13)
Authors: Yu, Lunyin; G. Garg, Hari; Li, Boyangzi; J. Linhardt, Robert; A. Hales, Charles

Favourites:Add to Favourites

The Biology of the Sodium Iodide Symporter and its Potential for Targeted Gene Delivery
pp. 242-267(26)
Authors: Hingorani, M.; Spitzweg, C.; Vassaux, G.; Newbold, K.; Melcher, A.; Pandha, H.; Vile, R.; Harrington, K.

Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more